We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.9B
AUM Growth
+$1.29B
Cap. Flow
+$573M
Cap. Flow %
1.31%
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Healthcare 13.05%
3 Financials 12.83%
4 Industrials 10.11%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABOS icon
2101
Acumen Pharmaceuticals
ABOS
$176M
$752K ﹤0.01%
310,797
+132,896
+75% +$423K
PUBM icon
2102
PubMatic
PUBM
$810M
$751K ﹤0.01%
36,998
+17,571
+90% +$392K
WLDN icon
2103
Willdan Group
WLDN
$1.3B
$751K ﹤0.01%
26,024
+3,731
+17% +$111K
EGRX
2104
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$750K ﹤0.01%
133,944
-29,491
-18% -$128K
RCI icon
2105
Rogers Communications
RCI
$18.6B
$750K ﹤0.01%
20,274
-662,115
-97% -$25.7M
PLAY icon
2106
Dave & Buster's
PLAY
$357M
$749K ﹤0.01%
+18,810
New +$977K
ORGO icon
2107
Organogenesis Holdings
ORGO
$239M
$749K ﹤0.01%
267,405
-202,445
-43% -$543K
CARE icon
2108
Carter Bankshares
CARE
$731M
$746K ﹤0.01%
49,345
+39,305
+391% +$492K
BCOV
2109
DELISTED
Brightcove, Inc.
BCOV
$746K ﹤0.01%
314,625
-74,249
-19% -$146K
CFB
2110
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$746K ﹤0.01%
53,177
-8,258
-13% -$107K
YMAB
2111
DELISTED
Y-mAbs Therapeutics
YMAB
$741K ﹤0.01%
61,316
-42,986
-41% -$580K
CATO icon
2112
Cato Corp
CATO
$66.1M
$739K ﹤0.01%
133,405
-6,613
-5% -$35.6K
SUPV
2113
Grupo Supervielle
SUPV
$753M
$739K ﹤0.01%
108,990
-26,293
-19% -$171K
TAC icon
2114
TransAlta
TAC
$3.93B
$738K ﹤0.01%
104,272
-848,495
-89% -$5.81M
UFI icon
2115
UNIFI
UFI
$134M
$738K ﹤0.01%
125,251
-38,323
-23% -$228K
REZI icon
2116
Resideo Technologies
REZI
$3.95B
$736K ﹤0.01%
37,648
+23,700
+170% +$490K
APAM icon
2117
Artisan Partners
APAM
$3.02B
$734K ﹤0.01%
17,777
-5,903
-25% -$255K
PLUG icon
2118
Plug Power
PLUG
$3.04B
$732K ﹤0.01%
+314,036
New +$899K
NGS icon
2119
Natural Gas Services Group
NGS
$477M
$730K ﹤0.01%
+36,266
New +$796K
MTRX icon
2120
Matrix Service
MTRX
$335M
$729K ﹤0.01%
73,374
-33,768
-32% -$386K
DIBS icon
2121
1stdibs.com
DIBS
$171M
$727K ﹤0.01%
161,956
+20,626
+15% +$113K
MREO
2122
Mereo BioPharma
MREO
$47.3M
$726K ﹤0.01%
201,776
-149,953
-43% -$486K
PPLI
2123
People Inc
PPLI
$3.1B
$725K ﹤0.01%
18,870
-174,969
-90% -$7.23M
CHCO icon
2124
City Holding Co
CHCO
$2.04B
$724K ﹤0.01%
+6,810
New +$700K
VIV icon
2125
Telefônica Brasil
VIV
$19.2B
$722K ﹤0.01%
+87,911
New +$795K

Similar funds

Two Sigma Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Two Sigma Investments held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Two Sigma Investments's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
  • Two Sigma Investments added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
  • Two Sigma Investments's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
  • Two Sigma Investments fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
  • Two Sigma Investments's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
  • Two Sigma Investments opened 479 new positions and closed 480 in Q2 2024.
  • Two Sigma Investments's portfolio value rose 3% quarter-over-quarter to $43.9B.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.